Vivus Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 59

Employees

  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 17

  • Investments
  • 3

Vivus General Information

Description

Operator of a biopharmaceutical company committed to the development and commercialization of clinical therapies and new treatment options. The company offers products to reduce calorie diet, increase physical activity, treatment of erectile dysfunction and weight management in adult patients.

Contact Information

Website
www.vivus.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 900 East Hamilton Avenue
  • Suite 550
  • Campbell, CA 95008
  • United States
+1 (888)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Icahn Enterprises
Vertical(s)
LOHAS & Wellness, Manufacturing
Corporate Office
  • 900 East Hamilton Avenue
  • Suite 550
  • Campbell, CA 95008
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vivus‘s full profile, request access.

Request a free trial

Vivus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company committed to the development and commercialization of clinical therapies and new
Drug Discovery
Campbell, CA
59 As of 2020

Melbourne, Australia
 

Sunnyvale, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivus Competitors (72)

One of Vivus’s 72 competitors is Mesoblast, a Corporation company based in Melbourne, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mesoblast Corporation Melbourne, Australia
BioCardia Formerly VC-backed Sunnyvale, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
CalciMedica Formerly VC-backed La Jolla, CA
Pharmacyclics Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 72 competitors. Get the full list »

Vivus Patents

  • 400

    Total Documents Applications and Grants

  • Total Patents Families

  • 111

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Vivus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230210793-A1 Method for rapid infusion of carmustine Pending 28-Jan-2022
US-20200108010-A1 Kit for preparing injectable carmustine solutions Inactive 04-Oct-2018
US-20210038543-A1 Kit for preparing injectable carmustine solutions Inactive 04-Oct-2018
US-20250339390-A1 Kit for preparing injectable carmustine solutions Pending 04-Oct-2018
US-20170319540-A1 Methods and compositions for the treatment of non-alcoholic steatohepatitis Inactive 06-May-2016 A61K31/357
To view Vivus’s complete patent history, request access »

Vivus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivus Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vivus‘s full profile, request access.

Request a free trial

Vivus Investments & Acquisitions (3)

Vivus’s most recent deal was a Corporate Asset Purchase with Janssen Pharmaceuticals (PANCREAZE) for . The deal was made on 08-Jun-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Janssen Pharmaceuticals (PANCREAZE) 08-Jun-2018 Corporate Asset Purchase Buildings and Property
Willow Biopharma 30-Apr-2018 Merger/Acquisition Pharmaceuticals
Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) 06-Jan-2017 Corporate Asset Purchase Buildings and Property
To view Vivus’s complete investments and acquisitions history, request access »

Vivus FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process